Cargando…
25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
BACKGROUND: Low 25‐hydroxyvitamin D (25[OH]D) is associated with increased cardiovascular disease risk. Less known is whether 25(OH)D deficiency contributes to subclinical myocardial damage and wall stress (high‐sensitivity cardiac troponin T [hs‐cTnT] and N‐terminal pro–brain natriuretic peptide [N...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210331/ https://www.ncbi.nlm.nih.gov/pubmed/27821403 http://dx.doi.org/10.1161/JAHA.116.003575 |
_version_ | 1782490863425814528 |
---|---|
author | Michos, Erin D. Selvin, Elizabeth Misialek, Jeffrey R. McEvoy, John W. Ndumele, Chiadi E. Folsom, Aaron R. Ballantyne, Christie M. Lutsey, Pamela L. |
author_facet | Michos, Erin D. Selvin, Elizabeth Misialek, Jeffrey R. McEvoy, John W. Ndumele, Chiadi E. Folsom, Aaron R. Ballantyne, Christie M. Lutsey, Pamela L. |
author_sort | Michos, Erin D. |
collection | PubMed |
description | BACKGROUND: Low 25‐hydroxyvitamin D (25[OH]D) is associated with increased cardiovascular disease risk. Less known is whether 25(OH)D deficiency contributes to subclinical myocardial damage and wall stress (high‐sensitivity cardiac troponin T [hs‐cTnT] and N‐terminal pro–brain natriuretic peptide [NT‐proBNP]) or whether associations vary among subgroups. METHODS AND RESULTS: Overall, 11 311 Atherosclerosis Risk in Communities participants without prevalent cardiovascular disease had 25(OH)D, hs‐cTnT, and NT‐proBNP measured at baseline (1990–1992), and 8990 had measurements of hs‐cTnT and NT‐proBNP repeated 6 years later. We examined associations of deficient 25(OH)D (<20 ng/mL) with prevalent elevated hs‐cTnT (≥14 ng/L) and NT‐proBNP (≥100 pg/mL), change in hs‐cTnT and NT‐proBNP, and incident elevated hs‐cTnT and NT‐proBNP. We tested for interactions by age (<56 and ≥56 years), sex, and race. In fully adjusted models, 25(OH)D was not associated with prevalent elevated hs‐cTnT and NT‐proBNP. Deficient 25(OH)D, however, was associated with increased 6‐year change in hs‐cTnT (β=0.54 ng/L [95% CI 0.08–1.01]) but not change in NT‐proBNP. Deficiency in 25(OH)D was not associated with incident elevated hs‐cTnT in the overall cohort but was associated with incident elevated hs‐cTnT in younger but not older adults (relative risk 2.18 [95% CI 1.21–3.94] versus 0.78 [95% CI 0.56–1.08], respectively; P=0.01 for interaction by age). Deficient 25(OH)D was also associated with incident elevated NT‐proBNP in men but not women (P=0.01 for interaction by sex). CONCLUSIONS: Vitamin D deficiency was associated with increased 6‐year change in hs‐cTnT levels. Hypothesis‐generating differences in associations by age and sex, but not race, were observed. If these associations are causal, further research is needed to understand mechanisms by which low 25(OH)D confers increased risk in these subgroups and whether treating deficient 25(OH)D can prevent myocardial damage and wall stress. |
format | Online Article Text |
id | pubmed-5210331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-52103312017-01-05 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study Michos, Erin D. Selvin, Elizabeth Misialek, Jeffrey R. McEvoy, John W. Ndumele, Chiadi E. Folsom, Aaron R. Ballantyne, Christie M. Lutsey, Pamela L. J Am Heart Assoc Original Research BACKGROUND: Low 25‐hydroxyvitamin D (25[OH]D) is associated with increased cardiovascular disease risk. Less known is whether 25(OH)D deficiency contributes to subclinical myocardial damage and wall stress (high‐sensitivity cardiac troponin T [hs‐cTnT] and N‐terminal pro–brain natriuretic peptide [NT‐proBNP]) or whether associations vary among subgroups. METHODS AND RESULTS: Overall, 11 311 Atherosclerosis Risk in Communities participants without prevalent cardiovascular disease had 25(OH)D, hs‐cTnT, and NT‐proBNP measured at baseline (1990–1992), and 8990 had measurements of hs‐cTnT and NT‐proBNP repeated 6 years later. We examined associations of deficient 25(OH)D (<20 ng/mL) with prevalent elevated hs‐cTnT (≥14 ng/L) and NT‐proBNP (≥100 pg/mL), change in hs‐cTnT and NT‐proBNP, and incident elevated hs‐cTnT and NT‐proBNP. We tested for interactions by age (<56 and ≥56 years), sex, and race. In fully adjusted models, 25(OH)D was not associated with prevalent elevated hs‐cTnT and NT‐proBNP. Deficient 25(OH)D, however, was associated with increased 6‐year change in hs‐cTnT (β=0.54 ng/L [95% CI 0.08–1.01]) but not change in NT‐proBNP. Deficiency in 25(OH)D was not associated with incident elevated hs‐cTnT in the overall cohort but was associated with incident elevated hs‐cTnT in younger but not older adults (relative risk 2.18 [95% CI 1.21–3.94] versus 0.78 [95% CI 0.56–1.08], respectively; P=0.01 for interaction by age). Deficient 25(OH)D was also associated with incident elevated NT‐proBNP in men but not women (P=0.01 for interaction by sex). CONCLUSIONS: Vitamin D deficiency was associated with increased 6‐year change in hs‐cTnT levels. Hypothesis‐generating differences in associations by age and sex, but not race, were observed. If these associations are causal, further research is needed to understand mechanisms by which low 25(OH)D confers increased risk in these subgroups and whether treating deficient 25(OH)D can prevent myocardial damage and wall stress. John Wiley and Sons Inc. 2016-11-07 /pmc/articles/PMC5210331/ /pubmed/27821403 http://dx.doi.org/10.1161/JAHA.116.003575 Text en © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Michos, Erin D. Selvin, Elizabeth Misialek, Jeffrey R. McEvoy, John W. Ndumele, Chiadi E. Folsom, Aaron R. Ballantyne, Christie M. Lutsey, Pamela L. 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study |
title | 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study |
title_full | 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study |
title_fullStr | 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study |
title_full_unstemmed | 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study |
title_short | 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study |
title_sort | 25‐hydroxyvitamin d levels and markers of subclinical myocardial damage and wall stress: the atherosclerosis risk in communities study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210331/ https://www.ncbi.nlm.nih.gov/pubmed/27821403 http://dx.doi.org/10.1161/JAHA.116.003575 |
work_keys_str_mv | AT michoserind 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy AT selvinelizabeth 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy AT misialekjeffreyr 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy AT mcevoyjohnw 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy AT ndumelechiadie 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy AT folsomaaronr 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy AT ballantynechristiem 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy AT lutseypamelal 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy |